Literature DB >> 7756291

Matrilysin-inhibitor complexes: common themes among metalloproteases.

M F Browner1, W W Smith, A L Castelhano.   

Abstract

Matrix metalloproteases are a family of enzymes that play critical roles in the physiological and pathological degradation of the extracellular matrix. These enzymes may be important therapeutic targets for the treatment of various diseases where tissue degradation is part of the pathology, such as cancer and arthritis. Matrilysin is the smallest member of this family of enzymes, all of which require zinc for catalytic activity. The first X-ray crystal structures of human matrilysin are presented. Inhibitors of metalloproteases are often characterized by the chemical group that interacts with the active site zinc of the protein. The structures of matrilysin complexed with hydroxamate (maximum resolution 1.9 A), carboxylate (maximum resolution 2.4 A), and sulfodiimine (maximum resolution 2.3 A) inhibitors are presented here and provide detailed information about how each functional group interacts with the catalytic zinc. Only the zinc-coordination group is variable in this series of inhibitors. Examination of these inhibitor-matrilysin complexes emphasizes the dominant role the zinc-coordinating group plays in determining the relative potencies of the inhibitors. The structures of these matrilysin-inhibitor complexes also provide a basis for comparing the catalytic mechanism of MMPs and other metalloproteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7756291     DOI: 10.1021/bi00020a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  35 in total

Review 1.  Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.

Authors:  Klaus Maskos; Wolfram Bode
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

2.  Enzyme-catalyzed gel proteolysis: an anomalous diffusion-controlled mechanism.

Authors:  G C Fadda; D Lairez; B Arrio; J-P Carton; V Larreta-Garde
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

Review 3.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

4.  A combination of docking, QM/MM methods, and MD simulation for binding affinity estimation of metalloprotein ligands.

Authors:  Akash Khandelwal; Viera Lukacova; Dogan Comez; Daniel M Kroll; Soumyendu Raha; Stefan Balaz
Journal:  J Med Chem       Date:  2005-08-25       Impact factor: 7.446

5.  Calcium regulates tertiary structure and enzymatic activity of human endometase/matrilysin-2 and its role in promoting human breast cancer cell invasion.

Authors:  Seakwoo Lee; Hyun I Park; Qing-Xiang Amy Sang
Journal:  Biochem J       Date:  2007-04-01       Impact factor: 3.857

6.  Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity.

Authors:  B C Finzel; E T Baldwin; G L Bryant; G F Hess; J W Wilks; C M Trepod; J E Mott; V P Marshall; G L Petzold; R A Poorman; T J O'Sullivan; H J Schostarez; M A Mitchell
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

7.  Structure of malonic acid-based inhibitors bound to human neutrophil collagenase. A new binding mode explains apparently anomalous data.

Authors:  H Brandstetter; R A Engh; E G Von Roedern; L Moroder; R Huber; W Bode; F Grams
Journal:  Protein Sci       Date:  1998-06       Impact factor: 6.725

8.  Anomalous pH-dependence of the activity of human matrilysin (matrix metalloproteinase-7) as revealed by nitration and amination of its tyrosine residues.

Authors:  Yuko Muta; Hiroshi Oneda; Kuniyo Inouye
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

9.  Computational insights into the selectivity mechanism of APP-IP over matrix metalloproteinases.

Authors:  Lingling Geng; Jian Gao; Wei Cui; Yancheng Tang; Mingjuan Ji; Bozhen Chen
Journal:  J Comput Aided Mol Des       Date:  2012-12-09       Impact factor: 3.686

10.  1H, 13C and 15N backbone resonance assignments of matrilysin (MMP7) complexed with a sulfonamide hydroxamate-type inhibitor.

Authors:  Li Ou; Qi Zhang; Jingbiao Ma; Wengen Wu; Zhonghua Wang; Fang Zhang; Dawei Ma; Houming Wu
Journal:  J Biomol NMR       Date:  2004-08       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.